Suppr超能文献

远端胃切除术后重建方法的临床结局比较:基于随机对照试验的系统评价和Meta分析

Comparison of the Clinical Outcomes of Reconstruction Methods After Distal Gastrectomy: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.

作者信息

Min Jae-Seok, Kim Rock Bum, Seo Kyung Won, Jeong Sang-Ho

机构信息

Department of Surgery, Dongnam Institute of Radiological and Medical Sciences, Cancer Center, Busan, Korea.

Regional Cardiocerebrovascular Disease Center, Gyeongsang National University Hospital, Jinju, Korea.

出版信息

J Gastric Cancer. 2022 Apr;22(2):83-93. doi: 10.5230/jgc.2022.22.e9.

Abstract

BACKGROUND

To analyze the short- and long-term clinical outcomes of 2 reconstruction methods after distal gastrectomy for gastric cancer.

METHODS

Three keywords, "gastric neoplasm," "distal gastrectomy," and "reconstruction," were used to search PubMed. We selected only randomized controlled trial that compared the anastomosis methods. A total of 11 papers and 8 studies were included in this meta-analysis. All statistical analyses were performed using the R software.

RESULTS

Among short-term clinical outcomes, a shorter operation time, reduced morbidity, and shorter hospital stay were found for Billroth type I (B-I) than for Roux-en-Y (RNY) reconstruction in the meta-analysis (P<0.001, P=0.048, P<0.001, respectively). When comparing Billroth type II (B-II) to RNY, the operation time was shorter for B-II than for RNY (P<0.019), but there were no differences in morbidity or length of hospital stay (P=0.500, P=0.259, respectively). Regarding long-term clinical outcomes related to reflux, there were significantly fewer incidents of reflux esophagitis, reflux gastritis, and bile reflux (P=0.035, P<0.001, P=0.019, respectively) for RNY than for B-I in the meta-analysis, but there was no difference between the 2 methods in residual food (P=0.545). When comparing B-II to RNY, there were significantly fewer incidents of reflux gastritis (P<0.001) for RNY than for B-II, but the amount of residual food and patient weight gain showed no difference.

CONCLUSION

B-I had the most favorable short-term outcomes, but RNY was more advantageous for long-term outcomes than for other methods. Surgeons should be aware of the advantages and disadvantages of each type of anastomosis and select the appropriate method.

摘要

背景

分析胃癌远端胃切除术后两种重建方法的短期和长期临床结局。

方法

使用“胃肿瘤”“远端胃切除术”和“重建”三个关键词检索PubMed。我们仅选择比较吻合方法的随机对照试验。本荟萃分析共纳入11篇论文和8项研究。所有统计分析均使用R软件进行。

结果

在短期临床结局方面,荟萃分析显示,毕Ⅰ式(B-I)重建的手术时间比 Roux-en-Y(RNY)重建短,发病率降低,住院时间缩短(分别为P<0.001、P=0.048、P<0.001)。将毕Ⅱ式(B-II)与RNY比较时,B-II的手术时间比RNY短(P<0.019),但发病率和住院时间无差异(分别为P=0.500、P=0.259)。关于与反流相关的长期临床结局,荟萃分析显示,RNY的反流性食管炎、反流性胃炎和胆汁反流事件明显少于B-I(分别为P=0.035、P<0.001、P=0.019),但两种方法在残食方面无差异(P=0.545)。将B-II与RNY比较时,RNY的反流性胃炎事件明显少于B-II(P<0.001),但残食量和患者体重增加无差异。

结论

B-I的短期结局最有利,但RNY在长期结局方面比其他方法更具优势。外科医生应了解每种吻合方式的优缺点并选择合适的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8068/9091459/a3d6369a93c9/jgc-22-83-g001.jpg

相似文献

5
Billroth I vs. Billroth II vs. Roux-en-Y following distal gastrectomy: a meta-analysis based on 15 studies.
Hepatogastroenterology. 2011 Jul-Aug;58(109):1413-24. doi: 10.5754/hge10567.
7
Roux-en-Y versus Billroth I reconstruction after distal gastrectomy for gastric cancer: a meta-analysis.
World J Gastroenterol. 2013 Feb 21;19(7):1124-34. doi: 10.3748/wjg.v19.i7.1124.
8
[Comparison of different reconstruction procedures after distal gastrectomy in patients with gastric cancer].
Zhonghua Yi Xue Za Zhi. 2020 Dec 29;100(48):3884-3889. doi: 10.3760/cma.j.cn112137-20200422-01279.
9
Optimal Reconstruction After Laparoscopic Distal Gastrectomy: A Single-Center Retrospective Study.
Cancer Control. 2022 Jan-Dec;29:10732748221087059. doi: 10.1177/10732748221087059.

本文引用的文献

1
Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2019.
J Gastric Cancer. 2021 Sep;21(3):221-235. doi: 10.5230/jgc.2021.21.e27. Epub 2021 Oct 1.
2
Cancer statistics for the year 2020: An overview.
Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588.
3
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018.
Cancer Res Treat. 2021 Apr;53(2):301-315. doi: 10.4143/crt.2021.291. Epub 2021 Mar 17.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验